Assessing the Impact of Targeted Screening and Treatment of Diabetes and Hypertension among Adults Living with HIV in Nairobi, Kenya
Individuals living with human immunodeficiency virus (HIV) today are living longer, thanks to expanded access to antiretroviral therapy (ART); however, this population is therefore increasingly at risk for many age-associated comorbidities. The future health of people living with HIV will therefore depend on the prevention and management of non-communicable diseases (NCDs), with consideration for integrated approaches to screening and treatment becoming increasingly important. This analysis applies a hybrid simulation of HIV and NCDs to examine the impact of providing screening and treatment for hypertension and diabetes at HIV facilities in Nairobi, Kenya. We combine a compartmental model of the HIV epidemic at a population level with a microsimulation of cardiovascular disease (CVD), and explore the impact of various strategies for targeting eligible individuals on ART, by age and gender, to receive NCD screening and treatment.
